ArticleBMJ open2022

Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case-control analyses from UK primary care.

Antonio González-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.